These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20447580)

  • 21. Cardiac resynchronization therapy: a review of clinical trials and criteria for identifying the appropriate patient.
    Abraham WT
    Rev Cardiovasc Med; 2003; 4 Suppl 2():S30-7. PubMed ID: 12776011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee.
    Stevenson WG; Hernandez AF; Carson PE; Fang JC; Katz SD; Spertus JA; Sweitzer NK; Tang WH; Albert NM; Butler J; Westlake Canary CA; Collins SP; Colvin-Adams M; Ezekowitz JA; Givertz MM; Hershberger RE; Rogers JG; Teerlink JR; Walsh MN; Stough WG; Starling RC;
    J Card Fail; 2012 Feb; 18(2):94-106. PubMed ID: 22300776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex.
    Jeevanantham V; Zareba W; Navaneethan S; Fitzgerald D; Yu CM; Achilli A; Bax J; Daubert J
    Cardiol J; 2008; 15(3):230-6. PubMed ID: 18651415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac resynchronization therapy in heart failure.
    Auricchio A; Fantoni C
    Ital Heart J; 2005 Mar; 6(3):256-60. PubMed ID: 15875517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac resynchronization therapy: a review of CRT-D versus CRT-P.
    Stabile G; Iuliano A; Turco P; Ciardiello C; De Simone A
    Future Cardiol; 2009 Nov; 5(6):567-72. PubMed ID: 19886783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac resynchronization therapy: device-based medicine for heart failure.
    Philippon F
    J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure.
    Bleeker GB; Schalij MJ; Molhoek SG; Verwey HF; Holman ER; Boersma E; Steendijk P; Van Der Wall EE; Bax JJ
    J Cardiovasc Electrophysiol; 2004 May; 15(5):544-9. PubMed ID: 15149423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in cardiac resynchronization therapy.
    Steffel J; Holzmeister J; Abraham WT
    Postgrad Med; 2011 Mar; 123(2):18-26. PubMed ID: 21474889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac resynchronization therapy.
    Abraham WT
    Prog Cardiovasc Dis; 2006; 48(4):232-8. PubMed ID: 16517245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy.
    van Gelder BM; Bracke FA; Meijer A; Lakerveld LJ; Pijls NH
    Am J Cardiol; 2004 Jun; 93(12):1500-3. PubMed ID: 15194020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
    Inage T; Yoshida T; Hiraki T; Ohe M; Takeuchi T; Nagamoto Y; Fukuda Y; Gondo T; Imaizumi T
    Europace; 2008 Mar; 10(3):379-83. PubMed ID: 18227354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS?
    Gasparini M; Regoli F; Galimberti P; Ceriotti C; Bonadies M; Mangiavacchi M; Andreuzzi B; Bragato R; Pini D; Klersy C; Gronda E
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S34-9. PubMed ID: 17302713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term hemodynamic effects of cardiac resynchronization therapy in patients with heart failure, a narrow QRS duration, and no dyssynchrony.
    Williams LK; Ellery S; Patel K; Leyva F; Bleasdale RA; Phan TT; Stegemann B; Paul V; Steendijk P; Frenneaux M
    Circulation; 2009 Oct; 120(17):1687-94. PubMed ID: 19822812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops.
    Steendijk P; Tulner SA; Bax JJ; Oemrawsingh PV; Bleeker GB; van Erven L; Putter H; Verwey HF; van der Wall EE; Schalij MJ
    Circulation; 2006 Mar; 113(10):1295-304. PubMed ID: 16520415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
    Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
    Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.